nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.0483	0.068	CcSEcCtD
Glipizide—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.0463	0.0652	CcSEcCtD
Glipizide—PPARG—forelimb—amyotrophic lateral sclerosis	0.0353	0.188	CbGeAlD
Glipizide—PPARG—hindlimb—amyotrophic lateral sclerosis	0.0318	0.169	CbGeAlD
Glipizide—PPARG—appendage—amyotrophic lateral sclerosis	0.0273	0.145	CbGeAlD
Glipizide—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0288	CcSEcCtD
Glipizide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0249	CcSEcCtD
Glipizide—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0243	CcSEcCtD
Glipizide—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0162	0.0228	CcSEcCtD
Glipizide—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0223	CcSEcCtD
Glipizide—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0213	CcSEcCtD
Glipizide—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0202	CcSEcCtD
Glipizide—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0196	CcSEcCtD
Glipizide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0135	0.019	CcSEcCtD
Glipizide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0185	CcSEcCtD
Glipizide—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0177	CcSEcCtD
Glipizide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0176	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0176	CcSEcCtD
Glipizide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0175	CcSEcCtD
Glipizide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0173	CcSEcCtD
Glipizide—Gliclazide—VEGFA—amyotrophic lateral sclerosis	0.0109	1	CrCbGaD
Glipizide—ABCC8—brainstem—amyotrophic lateral sclerosis	0.0109	0.0579	CbGeAlD
Glipizide—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0146	CcSEcCtD
Glipizide—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0145	CcSEcCtD
Glipizide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0142	CcSEcCtD
Glipizide—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00988	0.0139	CcSEcCtD
Glipizide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0094	0.0132	CcSEcCtD
Glipizide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00925	0.013	CcSEcCtD
Glipizide—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00912	0.0128	CcSEcCtD
Glipizide—PPARG—embryo—amyotrophic lateral sclerosis	0.00905	0.0482	CbGeAlD
Glipizide—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.009	0.0127	CcSEcCtD
Glipizide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00868	0.0122	CcSEcCtD
Glipizide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00866	0.0122	CcSEcCtD
Glipizide—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00862	0.0121	CcSEcCtD
Glipizide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0086	0.0121	CcSEcCtD
Glipizide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00809	0.0114	CcSEcCtD
Glipizide—Chills—Riluzole—amyotrophic lateral sclerosis	0.00777	0.0109	CcSEcCtD
Glipizide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0109	CcSEcCtD
Glipizide—ABCC8—medulla oblongata—amyotrophic lateral sclerosis	0.00757	0.0403	CbGeAlD
Glipizide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00743	0.0105	CcSEcCtD
Glipizide—Tension—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0104	CcSEcCtD
Glipizide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00732	0.0103	CcSEcCtD
Glipizide—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0102	CcSEcCtD
Glipizide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00706	0.00994	CcSEcCtD
Glipizide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.007	0.00984	CcSEcCtD
Glipizide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0068	0.00957	CcSEcCtD
Glipizide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00677	0.00953	CcSEcCtD
Glipizide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00952	CcSEcCtD
Glipizide—ABCC8—spinal cord—amyotrophic lateral sclerosis	0.00675	0.036	CbGeAlD
Glipizide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0095	CcSEcCtD
Glipizide—ABCC8—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.00672	0.074	CbGpPWpGaD
Glipizide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00663	0.00933	CcSEcCtD
Glipizide—KCNJ11—Inwardly rectifying K+ channels—KCNJ10—amyotrophic lateral sclerosis	0.00652	0.0718	CbGpPWpGaD
Glipizide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00651	0.00916	CcSEcCtD
Glipizide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00903	CcSEcCtD
Glipizide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00903	CcSEcCtD
Glipizide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0064	0.009	CcSEcCtD
Glipizide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00634	0.00893	CcSEcCtD
Glipizide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00873	CcSEcCtD
Glipizide—KCNJ11—nervous system—amyotrophic lateral sclerosis	0.00618	0.0329	CbGeAlD
Glipizide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00615	0.00866	CcSEcCtD
Glipizide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00852	CcSEcCtD
Glipizide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00848	CcSEcCtD
Glipizide—KCNJ11—central nervous system—amyotrophic lateral sclerosis	0.00595	0.0317	CbGeAlD
Glipizide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00595	0.00837	CcSEcCtD
Glipizide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00825	CcSEcCtD
Glipizide—KCNJ11—cerebellum—amyotrophic lateral sclerosis	0.00581	0.031	CbGeAlD
Glipizide—ABCC8—nervous system—amyotrophic lateral sclerosis	0.00569	0.0303	CbGeAlD
Glipizide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00561	0.00789	CcSEcCtD
Glipizide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00557	0.00783	CcSEcCtD
Glipizide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00553	0.00778	CcSEcCtD
Glipizide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00772	CcSEcCtD
Glipizide—ABCC8—central nervous system—amyotrophic lateral sclerosis	0.00548	0.0292	CbGeAlD
Glipizide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00547	0.0077	CcSEcCtD
Glipizide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00542	0.00762	CcSEcCtD
Glipizide—ABCC8—cerebellum—amyotrophic lateral sclerosis	0.00536	0.0285	CbGeAlD
Glipizide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00753	CcSEcCtD
Glipizide—PPARG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00531	0.0586	CbGpPWpGaD
Glipizide—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00531	0.00748	CcSEcCtD
Glipizide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00741	CcSEcCtD
Glipizide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00741	CcSEcCtD
Glipizide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00507	0.00714	CcSEcCtD
Glipizide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00708	CcSEcCtD
Glipizide—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00688	CcSEcCtD
Glipizide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00685	CcSEcCtD
Glipizide—KCNJ11—brain—amyotrophic lateral sclerosis	0.00472	0.0252	CbGeAlD
Glipizide—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00638	CcSEcCtD
Glipizide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00621	CcSEcCtD
Glipizide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00613	CcSEcCtD
Glipizide—ABCC8—brain—amyotrophic lateral sclerosis	0.00435	0.0232	CbGeAlD
Glipizide—PPARG—nervous system—amyotrophic lateral sclerosis	0.00434	0.0231	CbGeAlD
Glipizide—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00429	0.0472	CbGpPWpGaD
Glipizide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00592	CcSEcCtD
Glipizide—PPARG—central nervous system—amyotrophic lateral sclerosis	0.00418	0.0223	CbGeAlD
Glipizide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00573	CcSEcCtD
Glipizide—PPARG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00392	0.0432	CbGpPWpGaD
Glipizide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00551	CcSEcCtD
Glipizide—Rash—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00546	CcSEcCtD
Glipizide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00545	CcSEcCtD
Glipizide—Headache—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00542	CcSEcCtD
Glipizide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00514	CcSEcCtD
Glipizide—PPARG—brain—amyotrophic lateral sclerosis	0.00332	0.0177	CbGeAlD
Glipizide—PPARG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0031	0.0342	CbGpPWpGaD
Glipizide—ABCC8—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00265	0.0292	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.0026	0.0286	CbGpPWpGaD
Glipizide—KCNJ11—Potassium Channels—KCNJ10—amyotrophic lateral sclerosis	0.00257	0.0284	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00238	0.0262	CbGpPWpGaD
Glipizide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00194	0.0103	CbGeAlD
Glipizide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00187	0.00995	CbGeAlD
Glipizide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00158	0.0174	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00147	0.0162	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00134	0.0148	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.00123	0.0135	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00116	0.0128	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00112	0.0124	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00107	0.0118	CbGpPWpGaD
Glipizide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00104	0.0115	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00104	0.0114	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00103	0.0114	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00102	0.0112	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.001	0.011	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000944	0.0104	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000916	0.0101	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000878	0.00968	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000878	0.00968	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000862	0.00949	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000857	0.00944	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000851	0.00938	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000851	0.00938	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000784	0.00864	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000783	0.00862	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000759	0.00836	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000729	0.00803	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000693	0.00764	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00069	0.00761	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000685	0.00755	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000648	0.00714	CbGpPWpGaD
Glipizide—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000643	0.00709	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000555	0.00612	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000551	0.00607	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000535	0.0059	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000532	0.00587	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000532	0.00587	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000516	0.00569	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000516	0.00569	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000491	0.00541	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000487	0.00537	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000472	0.0052	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000472	0.0052	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000472	0.0052	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000469	0.00517	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000454	0.005	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000453	0.00499	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000453	0.00499	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000439	0.00484	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000426	0.00469	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000421	0.00464	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000413	0.00455	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00041	0.00452	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000389	0.00429	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000385	0.00424	CbGpPWpGaD
Glipizide—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000382	0.0042	CbGpPWpGaD
Glipizide—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000382	0.0042	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—DAO—amyotrophic lateral sclerosis	0.000373	0.00411	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000356	0.00392	CbGpPWpGaD
Glipizide—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000349	0.00385	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00034	0.00375	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000324	0.00358	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000316	0.00348	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000316	0.00348	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000306	0.00337	CbGpPWpGaD
Glipizide—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000305	0.00336	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000292	0.00321	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000289	0.00318	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000283	0.00312	CbGpPWpGaD
Glipizide—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000276	0.00304	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00027	0.00298	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000269	0.00297	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000268	0.00296	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSR—amyotrophic lateral sclerosis	0.000261	0.00288	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000258	0.00284	CbGpPWpGaD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000255	0.00281	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000252	0.00278	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000221	0.00244	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000214	0.00236	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000209	0.0023	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000193	0.00213	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000183	0.00202	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000181	0.00199	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.00194	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000173	0.00191	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000158	0.00175	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000145	0.00159	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000141	0.00155	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000141	0.00155	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000136	0.00149	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000131	0.00144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000129	0.00142	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00133	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000119	0.00132	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000119	0.00131	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000119	0.00131	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000115	0.00127	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000112	0.00124	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000109	0.0012	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000106	0.00117	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000102	0.00112	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.91e-05	0.00109	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	9.73e-05	0.00107	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	9.27e-05	0.00102	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	9.27e-05	0.00102	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—APOE—amyotrophic lateral sclerosis	8.98e-05	0.00099	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	8.74e-05	0.000963	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—APOE—amyotrophic lateral sclerosis	8.71e-05	0.00096	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.52e-05	0.000938	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	8.48e-05	0.000934	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.88e-05	0.000868	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.83e-05	0.000862	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	7.7e-05	0.000848	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	7.41e-05	0.000816	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	7.11e-05	0.000783	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	6.7e-05	0.000738	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.47e-05	0.000713	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	6.44e-05	0.00071	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.16e-05	0.000678	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.97e-05	0.000658	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	5.84e-05	0.000643	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.32e-05	0.000587	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.08e-05	0.00056	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	4.69e-05	0.000516	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000486	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	3.85e-05	0.000424	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.65e-05	0.000402	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.14e-05	0.000346	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.88e-05	0.000318	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.37e-05	0.000261	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.07e-05	0.000228	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000209	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.62e-05	0.000179	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.56e-05	0.000172	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.07e-05	0.000118	CbGpPWpGaD
